Product Details
SemenAssay®VTS - Liquefier (Enzyme Digestion Method)
The problem of semen liquification:
Fresh ejaculated human semen is distinctly coagulated and the
coagulum does not liquefy for at least 20 to 30 minutes. Commonly,
semen samples are rather viscous even after 30-45 minutes, but
beyond this, if liquification is not complete and the semen remains
viscous, the indications are that some abnormality of the normal
semen producing mechanisms exists and more specifically lack of an
enzymatic process catalyzed by a proteolytic enzyme present in the
prostatic secretions. Liquefaction is also necessary for proper
semen evaluation when analyzed manually or with the sperm quality
analyzer.
With the development of the various forms of assisted reproductive
techniques (ART) and the need to extract the maximum numbers and
quality of spermatozoa from the ejaculated semen has brought the
semen viscosity into focus again. Viscous specimens are extremely
difficult to manipulate in-vitro and may not allow the proper
separation and isolation either the appropriate numbers, quality of
sperm or both, necessary to achieve the in-vitro results. It is
because of these reasons that the VTS is introduced in the market
to enable the proper in-vitro manipulation of viscous semen. The
VLS can assist you prior to performance of routine semen analysis
and also the proper extraction of spermatozoa prior to their use in
various forms of ART including intra-uterine insemination.
The using method of VTS for treatment of semen viscosity
difficulties.
- Collect fresh semen via masturbation or other methods (i.e. by
wearing collecting condom for sexual intercourse).
- Semen sample should liquefy within 15-30 minutes of collection. If
not, the VTS liquefier may be used to treat the high viscosity of
sample.
- Add the dissolved liquefier to semen sample with a proportion of
1:100. Incubate the mixture for 30~60min at 37℃ after gently
aspirated by Pasteur pipette. Observe the situation of liquefaction
or viscosity.
Company Profile

BRED Life Science Technology Inc. specializes in developing, manufacturing and marketing
lab products in the field of reproductive medicine, offering
automatic assay platform and related products for infertility
diagnosis and ART treatment. Based on the test methods and standard
recommended by the World Health Organization, BRED develops serial
products for infertility diagnosis and ART treatment with
innovative technology. And these help promote the establishment and
popularization of standardization for reproductive medicine lab.
BRED own a completest range of relative products in the field of
reproductive medicine worldwide.The products are of independent
intellectual property right within BRED.
Our mission of development is to be devoted to providing the best
solutions and products for the clinical laboratory in reproductive
medicine with the aim to promote the development of human
reproductive health.
Our operating philosophy is putting people first, doing business on
the basis of honesty, forging ahead and working with diligence.
Welcome to visit our official website: www.spermfunc.com
